By peering into the eyes of mice and tracking their ocular movements, researchers made an unexpected discovery: the visual cortex – a region of the brain known to process sensory information …
Uncategorized
VIDEO: Features added to digital patient engagement platform
CHICAGO — At the Ophthalmology Innovation Summit here, Richard Awdeh, MD, founder of CheckedUp, talks about the new features and enhancements that have been added to the signature platform.
Uncategorized
VIDEO: Outgoing CEO of Novaliq gives update on company’s dry eye products
CHICAGO — At the Ophthalmology Innovation Summit here, Novaliq cofounder Bernhard Günther gives an update of the company’s dry eye products on the market in Europe and in the pipeline. In November, Günther will transition from his role as chief executive officer and become chief innovation officer. Christian Roesky, PhD, will become the CEO.
Uncategorized
Zeiss appoints Steven Schallhorn as chief medical officer for global ophthalmic devices
Steven C. Schallhorn, MD , has been appointed as chief medical officer for global ophthalmic devices at Carl Zeiss Meditec, the company announced in a press release.He will serve on the executive leadership team and help direct business and medical guidance on the clinical use of the company’s portfolio of ophthalmic diagnostic and surgical technologies.
Uncategorized
Global Age-related Macular Degeneration Market Growth of 7.37% CAGR by 2020 – Analysis, Technologies & Forecasts Report 2016-2020 – Vendors: Bayer Healthcare, Novartis, Alcon – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Age-related Macular Degeneration Market 2016-2020” report to their offering. The report forecasts the global age-related macular degeneration (AMD) market to grow a…
Uncategorized
VIDEO: SightLife subsidiary created to drive innovation in effort to cure corneal blindness
CHICAGO — SightLife President and CEO Monty Montoya announced at the Ophthalmology Innovation Summit the launch of SightLife Surgical, a new subsidiary aimed at eliminating corneal blindness worldwide by 2040.Created with $10 million in Series A financing from the health care investment firm Flying L Partners, SightLife Surgical is a for-profit subsidiary of the nonprofit SightLife.